Table A5.
Treatment Decision by Recurrence Score and ECOG PS
| Recurrence Score and ECOG PS | Total No. | With Chemotherapy |
||
|---|---|---|---|---|
| No. | % | 95% CI (%) | ||
| Low risk | ||||
| All | 879 | 53 | 6 | 5 to 8 |
| 0 | 683 | 45 | 7 | 5 to 9 |
| 1 | 192 | 8 | 4 | 2 to 8 |
| ≥ 2 | 4 | — | — | |
| Intermediate risk | ||||
| All | 609 | 261 | 43 | 39 to 47 |
| 0 | 450 | 192 | 43 | 38 to 47 |
| 1 | 153 | 67 | 44 | 36 to 52 |
| ≥ 2 | 6 | 2 | 33 | 4 to 78 |
| High risk | ||||
| All | 159 | 134 | 84 | 78 to 90 |
| 0 | 117 | 99 | 85 | 77 to 91 |
| 1 | 37 | 31 | 84 | 68 to 94 |
| ≥ 2 | 5 | 4 | 80 | 28 to 99 |
| No test | ||||
| All | 3,818 | 707 | 19 | 18 to 20 |
| 0 | 2,523 | 491 | 19 | 18 to 21 |
| 1 | 1,151 | 213 | 19 | 16 to 21 |
| ≥ 2 | 144 | 3 | 2 | 0 to 6 |
NOTE. Seven hundred sixty-four patients with missing tumor grade (175 with recurrence schore, 589 without recurrence score) were excluded.
Abbreviation: ECOG PS, Eastern Cooperative Oncology Group performance status.